Annual Gross Profit
$2.07 B
+$285.30 M+15.99%
31 December 2023
Summary:
United Therapeutics annual gross profit is currently $2.07 billion, with the most recent change of +$285.30 million (+15.99%) on 31 December 2023. During the last 3 years, it has risen by +$507.00 million (+32.44%). UTHR annual gross profit is now at all-time high.UTHR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$665.80 M
+$28.70 M+4.50%
30 September 2024
Summary:
United Therapeutics quarterly gross profit is currently $665.80 million, with the most recent change of +$28.70 million (+4.50%) on 30 September 2024. Over the past year, it has increased by +$122.10 million (+22.46%). UTHR quarterly gross profit is now at all-time high.UTHR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$2.45 B
+$126.50 M+5.44%
30 September 2024
Summary:
United Therapeutics TTM gross profit is currently $2.45 billion, with the most recent change of +$126.50 million (+5.44%) on 30 September 2024. Over the past year, it has increased by +$381.40 million (+18.43%). UTHR TTM gross profit is now at all-time high.UTHR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +22.5% | +18.4% |
| 3 y3 years | +32.4% | +74.9% | +56.8% |
| 5 y5 years | +55.5% | +135.8% | +84.2% |
UTHR Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.4% | at high | +74.9% | at high | +56.8% |
| 5 y | 5 years | at high | +55.5% | at high | +135.8% | at high | +87.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
United Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $665.80 M(+4.5%) | $2.45 B(+5.4%) |
| June 2024 | - | $637.10 M(+5.3%) | $2.32 B(+4.7%) |
| Mar 2024 | - | $604.80 M(+11.2%) | $2.22 B(+7.3%) |
| Dec 2023 | $2.07 B(+16.0%) | $543.70 M(+0.8%) | $2.07 B(+5.7%) |
| Sept 2023 | - | $539.30 M(+1.3%) | $1.96 B(+3.2%) |
| June 2023 | - | $532.40 M(+17.1%) | $1.90 B(+5.3%) |
| Mar 2023 | - | $454.60 M(+5.1%) | $1.80 B(+1.0%) |
| Dec 2022 | $1.78 B(+14.2%) | $432.70 M(-9.6%) | $1.78 B(+3.0%) |
| Sept 2022 | - | $478.80 M(+9.5%) | $1.73 B(+3.7%) |
| June 2022 | - | $437.20 M(+0.3%) | $1.67 B(+1.7%) |
| Mar 2022 | - | $436.00 M(+14.6%) | $1.64 B(+5.1%) |
| Dec 2021 | $1.56 B(+13.7%) | $380.60 M(-8.7%) | $1.56 B(+2.0%) |
| Sept 2021 | - | $417.00 M(+1.9%) | $1.53 B(+4.1%) |
| June 2021 | - | $409.30 M(+14.9%) | $1.47 B(+5.2%) |
| Mar 2021 | - | $356.10 M(+1.7%) | $1.40 B(+1.7%) |
| Dec 2020 | $1.38 B(+3.3%) | $350.10 M(-1.7%) | $1.38 B(+5.2%) |
| Sept 2020 | - | $356.10 M(+6.0%) | $1.31 B(-0.9%) |
| June 2020 | - | $336.10 M(+1.0%) | $1.32 B(-0.8%) |
| Mar 2020 | - | $332.90 M(+17.9%) | $1.33 B(-0.0%) |
| Dec 2019 | $1.33 B(-6.9%) | $282.30 M(-23.4%) | $1.33 B(-4.8%) |
| Sept 2019 | - | $368.50 M(+6.2%) | $1.40 B(+0.6%) |
| June 2019 | - | $346.90 M(+4.0%) | $1.39 B(-2.5%) |
| Mar 2019 | - | $333.50 M(-4.6%) | $1.43 B(-0.2%) |
| Dec 2018 | $1.43 B(-11.8%) | $349.50 M(-3.1%) | $1.43 B(-4.2%) |
| Sept 2018 | - | $360.80 M(-5.7%) | $1.49 B(-4.2%) |
| June 2018 | - | $382.80 M(+13.9%) | $1.56 B(-2.7%) |
| Mar 2018 | - | $336.00 M(-18.4%) | $1.60 B(-1.2%) |
| Dec 2017 | $1.62 B(+6.1%) | $411.70 M(-3.4%) | $1.62 B(+2.0%) |
| Sept 2017 | - | $426.00 M(+0.1%) | $1.59 B(+2.7%) |
| June 2017 | - | $425.70 M(+19.5%) | $1.55 B(+2.2%) |
| Mar 2017 | - | $356.20 M(-6.4%) | $1.51 B(-0.8%) |
| Dec 2016 | $1.53 B(+9.3%) | $380.60 M(-1.0%) | $1.53 B(+0.1%) |
| Sept 2016 | - | $384.60 M(-2.0%) | $1.53 B(+0.3%) |
| June 2016 | - | $392.60 M(+6.6%) | $1.52 B(+4.2%) |
| Mar 2016 | - | $368.30 M(-3.0%) | $1.46 B(+4.4%) |
| Dec 2015 | $1.40 B(+20.1%) | $379.60 M(+0.1%) | $1.40 B(+3.6%) |
| Sept 2015 | - | $379.30 M(+14.5%) | $1.35 B(+7.2%) |
| June 2015 | - | $331.20 M(+8.0%) | $1.26 B(+3.9%) |
| Mar 2015 | - | $306.70 M(-7.2%) | $1.21 B(+4.1%) |
| Dec 2014 | $1.16 B(+17.9%) | $330.56 M(+14.3%) | $1.16 B(+7.4%) |
| Sept 2014 | - | $289.15 M(+1.8%) | $1.08 B(+1.7%) |
| June 2014 | - | $284.09 M(+9.8%) | $1.06 B(+3.5%) |
| Mar 2014 | - | $258.80 M(+3.4%) | $1.03 B(+4.4%) |
| Dec 2013 | $985.86 M(+23.7%) | $250.24 M(-7.8%) | $985.86 M(+4.7%) |
| Sept 2013 | - | $271.51 M(+9.4%) | $941.77 M(+6.4%) |
| June 2013 | - | $248.29 M(+15.0%) | $884.76 M(+6.3%) |
| Mar 2013 | - | $215.82 M(+4.7%) | $832.42 M(+4.5%) |
| Dec 2012 | $796.78 M | $206.15 M(-3.9%) | $796.78 M(+4.8%) |
| Sept 2012 | - | $214.50 M(+9.5%) | $760.48 M(+4.9%) |
| June 2012 | - | $195.94 M(+8.7%) | $725.04 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $180.18 M(+6.1%) | $691.69 M(+5.7%) |
| Dec 2011 | $654.28 M(+24.6%) | $169.85 M(-5.1%) | $654.28 M(+3.9%) |
| Sept 2011 | - | $179.07 M(+10.1%) | $629.58 M(+5.1%) |
| June 2011 | - | $162.59 M(+13.9%) | $598.94 M(+7.8%) |
| Mar 2011 | - | $142.77 M(-1.6%) | $555.81 M(+5.5%) |
| Dec 2010 | $525.23 M(+61.8%) | $145.16 M(-2.2%) | $527.03 M(+10.4%) |
| Sept 2010 | - | $148.42 M(+24.2%) | $477.30 M(+15.5%) |
| June 2010 | - | $119.46 M(+4.8%) | $413.34 M(+12.4%) |
| Mar 2010 | - | $113.99 M(+19.5%) | $367.78 M(+13.3%) |
| Dec 2009 | $324.53 M(+29.1%) | $95.43 M(+13.0%) | $324.53 M(+9.3%) |
| Sept 2009 | - | $84.46 M(+14.3%) | $296.86 M(+6.1%) |
| June 2009 | - | $73.90 M(+4.5%) | $279.69 M(+4.7%) |
| Mar 2009 | - | $70.74 M(+4.4%) | $267.01 M(+6.2%) |
| Dec 2008 | $251.43 M(+33.3%) | $67.75 M(+0.7%) | $251.43 M(+6.0%) |
| Sept 2008 | - | $67.29 M(+9.9%) | $237.22 M(+6.5%) |
| June 2008 | - | $61.22 M(+11.0%) | $222.81 M(+7.1%) |
| Mar 2008 | - | $55.16 M(+3.0%) | $208.07 M(+10.3%) |
| Dec 2007 | $188.68 M(+32.3%) | $53.54 M(+1.3%) | $188.68 M(+7.1%) |
| Sept 2007 | - | $52.88 M(+13.7%) | $176.21 M(+10.4%) |
| June 2007 | - | $46.49 M(+30.0%) | $159.58 M(+7.0%) |
| Mar 2007 | - | $35.77 M(-12.9%) | $149.09 M(+4.5%) |
| Dec 2006 | $142.60 M(+37.6%) | $41.07 M(+13.3%) | $142.60 M(+11.4%) |
| Sept 2006 | - | $36.24 M(+0.7%) | $128.02 M(+5.5%) |
| June 2006 | - | $36.00 M(+22.9%) | $121.35 M(+8.1%) |
| Mar 2006 | - | $29.29 M(+10.6%) | $112.23 M(+8.3%) |
| Dec 2005 | $103.60 M(+58.6%) | $26.49 M(-10.4%) | $103.60 M(+7.4%) |
| Sept 2005 | - | $29.58 M(+10.0%) | $96.47 M(+13.9%) |
| June 2005 | - | $26.88 M(+30.2%) | $84.73 M(+14.3%) |
| Mar 2005 | - | $20.65 M(+6.7%) | $74.10 M(+13.4%) |
| Dec 2004 | $65.34 M(+40.3%) | $19.36 M(+8.6%) | $65.34 M(+12.1%) |
| Sept 2004 | - | $17.84 M(+9.7%) | $58.29 M(+8.5%) |
| June 2004 | - | $16.26 M(+36.7%) | $53.74 M(+8.7%) |
| Mar 2004 | - | $11.89 M(-3.4%) | $49.44 M(+6.2%) |
| Dec 2003 | $46.56 M(+88.8%) | $12.31 M(-7.3%) | $46.56 M(+4.0%) |
| Sept 2003 | - | $13.28 M(+11.1%) | $44.77 M(+26.7%) |
| June 2003 | - | $11.96 M(+32.7%) | $35.34 M(+7.0%) |
| Mar 2003 | - | $9.01 M(-14.4%) | $33.04 M(+33.9%) |
| Dec 2002 | $24.66 M(+850.4%) | $10.52 M(+173.1%) | $24.66 M(+64.3%) |
| Sept 2002 | - | $3.85 M(-60.1%) | $15.01 M(+29.2%) |
| June 2002 | - | $9.65 M(+1417.5%) | $11.62 M(+354.8%) |
| Mar 2002 | - | $636.00 K(-27.1%) | $2.55 M(-21.6%) |
| Dec 2001 | $2.60 M(+655.5%) | $872.10 K(+91.0%) | $3.26 M(+32.3%) |
| Sept 2001 | - | $456.50 K(-22.5%) | $2.46 M(+14.1%) |
| June 2001 | - | $589.20 K(-56.0%) | $2.16 M(+25.7%) |
| Mar 2001 | - | $1.34 M(+1621.6%) | $1.72 M(+400.0%) |
| Dec 2000 | $343.50 K(-135.7%) | $77.80 K(-48.7%) | $343.50 K(+29.3%) |
| Sept 2000 | - | $151.80 K(+2.2%) | $265.70 K(+133.3%) |
| June 2000 | - | $148.60 K(-528.2%) | $113.90 K(-428.2%) |
| Mar 2000 | - | -$34.70 K | -$34.70 K |
| Dec 1999 | -$963.50 K | - | - |
FAQ
- What is United Therapeutics annual gross profit?
- What is the all time high annual gross profit for United Therapeutics?
- What is United Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for United Therapeutics?
- What is United Therapeutics quarterly gross profit year-on-year change?
- What is United Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for United Therapeutics?
- What is United Therapeutics TTM gross profit year-on-year change?
What is United Therapeutics annual gross profit?
The current annual gross profit of UTHR is $2.07 B
What is the all time high annual gross profit for United Therapeutics?
United Therapeutics all-time high annual gross profit is $2.07 B
What is United Therapeutics quarterly gross profit?
The current quarterly gross profit of UTHR is $665.80 M
What is the all time high quarterly gross profit for United Therapeutics?
United Therapeutics all-time high quarterly gross profit is $665.80 M
What is United Therapeutics quarterly gross profit year-on-year change?
Over the past year, UTHR quarterly gross profit has changed by +$122.10 M (+22.46%)
What is United Therapeutics TTM gross profit?
The current TTM gross profit of UTHR is $2.45 B
What is the all time high TTM gross profit for United Therapeutics?
United Therapeutics all-time high TTM gross profit is $2.45 B
What is United Therapeutics TTM gross profit year-on-year change?
Over the past year, UTHR TTM gross profit has changed by +$381.40 M (+18.43%)